Cargando…

Proteomic profiling reveals a signature for optimizing prognostic prediction in Colon Cancer

Previous studies developed prognostic signatures largely depended on transcriptome profiles. The purpose of our present study was to develop a proteomic signature to optimize the evaluation of prognosis of colon cancer patients. The proteomic data of colon cancer patient cohorts were downloaded from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shan, Zezhi, Luo, Dakui, Liu, Qi, Cai, Sanjun, Wang, Renjie, Ma, Yanlei, Li, Xinxiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7974900/ https://www.ncbi.nlm.nih.gov/pubmed/33758598 http://dx.doi.org/10.7150/jca.50630

Ejemplares similares

A Novel Seventeen-Gene Metabolic Signature for Predicting Prognosis in Colon Cancer
por: Luo, Dakui, et al.
Publicado: (2020)

The correlation between tumor size, lymph node status, distant metastases and mortality in rectal cancer patients without neoadjuvant therapy
por: Luo, Dakui, et al.
Publicado: (2021)

Evaluation of Traditional Prognostic Factors for Stage I-III Colorectal Cancer Patients Who Survived for Over Five Years After Surgery
por: Luo, Dakui, et al.
Publicado: (2021)

Palliative beam radiotherapy offered real-world survival benefit to metastatic rectal cancer: A large US population-based and propensity score-matched study
por: Liu, Qi, et al.
Publicado: (2019)

P–TNM staging system for colon cancer: combination of P-stage and AJCC TNM staging system for improving prognostic prediction and clinical management
por: Liu, Qi, et al.
Publicado: (2018)

A novel epithelial‐mesenchymal transition molecular signature predicts the oncological outcomes in colorectal cancer
por: Shan, Zezhi, et al.
Publicado: (2021)

Clinicopathological Features of Stage I–III Colorectal Cancer Recurrence Over 5 Years After Radical Surgery Without Receiving Neoadjuvant Therapy: Evidence From a Large Sample Study
por: Luo, Dakui, et al.
Publicado: (2021)

Evaluating the Guiding Role of Elevated Pretreatment Serum Carcinoembryonic Antigen Levels for Adjuvant Chemotherapy in Stage IIA Colon Cancer: A Large Population-Based and Propensity Score-Matched Study
por: Liu, Qi, et al.
Publicado: (2019)

Real-World Implications of Nonbiological Factors with Staging, Prognosis and Clinical Management in Colon Cancer
por: Liu, Qi, et al.
Publicado: (2018)

Survival Benefit of Preoperative Versus Postoperative Radiotherapy in Metastatic Rectal Cancer Treated With Definitive Surgical Resection of Primary Tumor: A Population Based, Propensity Score-Matched Study
por: Luo, Dakui, et al.
Publicado: (2019)

Circulating basophil count as a prognostic marker of tumor aggressiveness and survival outcomes in colorectal cancer
por: Liu, Qi, et al.
Publicado: (2020)

Circumferential resection margin as a prognostic factor after rectal cancer surgery: A large population‐based retrospective study
por: Liu, Qi, et al.
Publicado: (2018)

Associations of P Score With Real-World Survival Improvement Offered by Adjuvant Chemotherapy in Stage II Colon Cancer: A Large Population-Based Longitudinal Cohort Study
por: Liu, Qi, et al.
Publicado: (2021)

Survival benefit of adjuvant chemotherapy for patients with poorly differentiated stage IIA colon cancer
por: Liu, Qi, et al.
Publicado: (2019)

Incidence, predictors and prognostic implications of positive circumferential resection margin in colon cancer: A retrospective study in a Chinese high-volume cancer center
por: Luo, Dakui, et al.
Publicado: (2022)

ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial
por: Li, Qingguo, et al.
Publicado: (2019)

Combination of carcinoembryonic antigen with the American Joint Committee on Cancer TNM staging system in rectal cancer: a real-world and large population-based study
por: Liu, Qi, et al.
Publicado: (2018)

PROX1 restrains ferroptosis via SCD transcription activation in colorectal cancer: PROX1 inhibits ferroptosis in CRC
por: Zhang, Ruoxin, et al.
Publicado: (2023)

Evaluating the Effect of Lymph Node Status on Survival in Large Colon Cancer
por: Liu, Qi, et al.
Publicado: (2018)

Klotho negatively regulated aerobic glycolysis in colorectal cancer via ERK/HIF1α axis
por: Li, Qingguo, et al.
Publicado: (2018)

CUL4B-DDB1-COP1-mediated UTX downregulation promotes colorectal cancer progression
por: Luo, Dakui, et al.
Publicado: (2023)

TPX2 is a novel prognostic marker for the growth and metastasis of colon cancer
por: Wei, Ping, et al.
Publicado: (2013)

circCAPRIN1 interacts with STAT2 to promote tumor progression and lipid synthesis via upregulating ACC1 expression in colorectal cancer
por: Yang, Yufei, et al.
Publicado: (2022)

Comprehensive Transcriptomic Analysis Reveals Prognostic Value of an EMT-Related Gene Signature in Colorectal Cancer
por: Mo, Shaobo, et al.
Publicado: (2021)

Pretreatment Carcinoembryonic Antigen Level Serves as a Potential Biomarker to Guide Adjuvant Radiotherapy in pT4N+ Colon Cancer Patients
por: Luo, Dakui, et al.
Publicado: (2023)

Human oral microbiome dysbiosis as a novel non-invasive biomarker in detection of colorectal cancer
por: Zhang, Sheng, et al.
Publicado: (2020)

Loss of Yes-associated Protein Represents an Aggressive Subtype of Colorectal Cancer
por: Zhang, Sheng, et al.
Publicado: (2019)

Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer
por: Yang, Yongzhi, et al.
Publicado: (2019)

Prognostic and predictive value of radiomics signatures in stage I‐III colon cancer
por: Dai, Weixing, et al.
Publicado: (2020)

FBW7 suppresses metastasis of colorectal cancer by inhibiting HIF1α/CEACAM5 functional axis
por: Li, Qingguo, et al.
Publicado: (2018)

Development and validation of a chromatin regulator prognostic signature in colon adenocarcinoma
por: Yang, Wenlong, et al.
Publicado: (2022)

Association between Fusobacterium nucleatum and colorectal cancer: Progress and future directions
por: Zhang, Sheng, et al.
Publicado: (2018)

Nomograms for predicting the prognostic value of serological tumor biomarkers in colorectal cancer patients after radical resection
por: Li, Qingguo, et al.
Publicado: (2017)

Stroma Transcriptomic and Proteomic Profile of Prostate Cancer Metastasis Xenograft Models Reveals Prognostic Value of Stroma Signatures
por: Karkampouna, Sofia, et al.
Publicado: (2020)

LINE-1 hypomethylation in normal colon mucosa is associated with poor survival in Chinese patients with sporadic colon cancer
por: Zhuo, Changhua, et al.
Publicado: (2015)

A Novel Prognostic Model Incorporating Carcinoembryonic Antigen in 3-Week or Longer Postoperative Period for Stage III Colon Cancer: A Multicenter Retrospective Study
por: Fan, Jin, et al.
Publicado: (2020)

Effect of interval between neoadjuvant chemoradiotherapy and surgery on oncological outcomes in poor responders with locally advanced rectal cancer: a retrospective cohort study
por: Luo, Dakui, et al.
Publicado: (2023)

Prognostic nomograms for predicting cause-specific survival and overall survival of stage I–III colon cancer patients: a large population-based study
por: Zhou, Zheng, et al.
Publicado: (2019)

A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma
por: Zhong, Like, et al.
Publicado: (2023)

The Characteristics and Prognostic Effect of E-Cadherin Expression in Colorectal Signet Ring Cell Carcinoma
por: Wang, Renjie, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_sdl3tmc5r90ktqtdm25rsugft6